RLAY stock

Relay Therapeutics Inc (RLAY) financials · rev $15.4M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Relay Therapeutics Inc (RLAY) rev $15.4M.

Cached annual income statement
LineFY2025FY2024
Revenue$15.4M$10.0M
Operating Income-$302.7M-$372.5M
Net Income-$276.5M-$337.7M
EPS (Diluted)-$1.61-$2.36
Cached annual balance sheet
LineFY2025FY2024
Total Assets$621.3M$871.3M
Current Assets$578.3M$809.2M
Cash & Equivalents$84.0M$124.3M
PP&E$1.73M$5.91M
Total Liabilities$54.3M$93.5M
Current Liabilities$25.6M$50.7M
Shareholders' Equity$567.1M$777.8M
Retained Earnings-$2.01B-$1.74B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$235.5M-$249.1M
CapEx$410.0K$2.02M
Investing Cash Flow$192.8M-$41.1M
Financing Cash Flow$1.60M$270.2M
Net Change in Cash-$41.1M-$20.0M
Free Cash Flow-$235.9M-$251.1M
These statements as JSON? API free 100/day

FAQ

What is RLAY P/E and revenue?

Relay Therapeutics Inc (RLAY) rev $15.4M.

What is RLAY revenue?

Relay Therapeutics Inc last cached revenue is $15.4M (FY2025).

Is RLAY profitable?

Relay Therapeutics Inc last cached net income is -$276.5M (FY2025).

What are RLAY total assets?

Relay Therapeutics Inc last cached total assets are $621.3M (FY2025).

What is RLAY free cash flow?

Relay Therapeutics Inc last cached free cash flow is -$235.9M (FY2025).

Not investment advice. Cached statements, not a live tape.